Patients with coronary artery disease experience decreased oxygen delivery to the heart due to plaque or cholesterol build-up inside arteries.
Dr. Deepak Thekkoott, medical director at Lane Cardiovascular Center, was the first physician to use the ILUMIEN system at Lane.
The key to optimizing treatment of coronary artery disease is knowing which blockage needs treatment and how to treat it,” said Dr. Thekkoott. “The ILUMIEN system allows physicians to identify the precise measurements and dimensions of narrowed arteries responsible for obstructing blood flow to the patient’s heart.”
The ILUMIEN system combines optical coherence tomography (OCT) and fractional flow reserve (FFR) technologies on one platform:
OCT technology is used to visualize and measure important vessel characteristics that are used in guiding stent selection and deployment and also provides post-stenting information to ensure the procedure was successful.
FFR technology is used to determine the severity of blood flow blockages in coronary arteries to better identify specific narrowings.
The ILUMIEN system received U.S. Food and Drug Administration and European CE Mark approval in October of 2011.
For appointments with Dr. Deepak Thekkoott, please call 225-654-1559.